Does MIANSERIN Cause Transplant rejection? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Transplant rejection have been filed in association with MIANSERIN. This represents 0.2% of all adverse event reports for MIANSERIN.
6
Reports of Transplant rejection with MIANSERIN
0.2%
of all MIANSERIN reports
6
Deaths
5
Hospitalizations
How Dangerous Is Transplant rejection From MIANSERIN?
Of the 6 reports, 6 (100.0%) resulted in death, 5 (83.3%) required hospitalization.
Is Transplant rejection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIANSERIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does MIANSERIN Cause?
Toxicity to various agents (246)
Fall (201)
Coma (177)
Somnolence (163)
Off label use (141)
Drug abuse (132)
Confusional state (126)
Hyponatraemia (122)
Hypotension (113)
Poisoning deliberate (107)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
Which MIANSERIN Alternatives Have Lower Transplant rejection Risk?
MIANSERIN vs MICAFUNGIN
MIANSERIN vs MICARDIS
MIANSERIN vs MICONAZOLE
MIANSERIN vs MIDAZOLAM
MIANSERIN vs MIDAZOLAM\MIDAZOLAM